Research Article
Sulfated Alkyl Glucopyranans with Potent Antiviral Activity Synthesized by Ring-Opening Copolymerization of Anhydroglucose and Alkyl Anhydroglucose Monomers
Table 4
Apparent kinetic resultsa and DLS measurementsb of 3-O-octadecyl(16)--D-glucopyranans in the presence or absence of poly-L-lysine.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sulfated 3-O-octadecyl(16)--D-glucopyranans were injected 90 L for 180 s at a flow rate of a HBS-EP running buffer (pH = 7.4) at 25°C and then the running buffer was further flowed for 600 s. Concentrations of 3-O-octadecyl(16)--D-glucopyranans were 500, 250, 125, 62.5, and 31.3 g/mL, respectively. CM5 sensor chip immobilized poly-L-lysine was used. bThe particle size (nm) and zeta potential (mV) of the sulfated 3-O-octadecyl(16)--D-glucopyranans in the presence or absence of poly-L-lysine were determined at 25°C by a dynamic light scattering measurement in phosphate buffer solution (pH = 7.4) at a concentration of 1 mg/mL or 0.5 mg/mL. Before measuring, all samples were subjected to ultrasonication for 5 min. cCommercially available poly-L-lysine (1 mg/mL or 0.5 mg/mL) with the molecular weight of 1000–5000 was used. The particle size and zeta potential were 40.7 ± 6.9 nm and +0.41 mV, respectively. dDegree of sulfation was calculated from the results of the elemental analysis. eSoluble part in phosphate buffer (pH = 7.4) was measured. fStandard dextran sulfate with = 8.5 × 103 was used. |